BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33779789)

  • 1. [Rare bone disorders and respective treatments].
    Seefried L; Jakob F
    Internist (Berl); 2021 May; 62(5):486-495. PubMed ID: 33779789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials in skeletal dysplasia: a paradigm for treating rare diseases.
    Sabir A; Irving M
    Br Med Bull; 2021 Sep; 139(1):16-35. PubMed ID: 34453435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis of hypophosphatasia and differential diagnosis by targeted Next Generation Sequencing.
    Taillandier A; Domingues C; De Cazanove C; Porquet-Bordes V; Monnot S; Kiffer-Moreira T; Rothenbuhler A; Guggenbuhl P; Cormier C; Baujat G; Debiais F; Capri Y; Cohen-Solal M; Parent P; Chiesa J; Dieux A; Petit F; Roume J; Isnard M; Cormier-Daire V; Linglart A; Millán JL; Salles JP; Muti C; Simon-Bouy B; Mornet E
    Mol Genet Metab; 2015 Nov; 116(3):215-20. PubMed ID: 26432670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic options for bone diseases.
    Kocijan R; Haschka J; Feurstein J; Zwerina J
    Wien Med Wochenschr; 2021 Apr; 171(5-6):120-125. PubMed ID: 33512621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of the nosology of osteogenesis imperfecta.
    Chetty M; Roomaney IA; Beighton P
    Clin Genet; 2021 Jan; 99(1):42-52. PubMed ID: 32901963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolving therapeutic landscape of genetic skeletal disorders.
    Sabir AH; Cole T
    Orphanet J Rare Dis; 2019 Dec; 14(1):300. PubMed ID: 31888683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New perspectives on the treatment of skeletal dysplasia.
    Marzin P; Cormier-Daire V
    Ther Adv Endocrinol Metab; 2020; 11():2042018820904016. PubMed ID: 32166011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal Dysplasias: What Every Bone Health Clinician Needs to Know.
    Nikkel SM
    Curr Osteoporos Rep; 2017 Oct; 15(5):419-424. PubMed ID: 28808977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical condition and therapy of bone diseases].
    Miura K; Oznono K
    Clin Calcium; 2013 Dec; 23(12):1789-94. PubMed ID: 24292534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteogenesis imperfecta and other heritable disorders of bone.
    Paterson CR
    Baillieres Clin Endocrinol Metab; 1997 Apr; 11(1):195-213. PubMed ID: 9222492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy in Rare Skeletal Diseases.
    Hoyer-Kuhn H; Schönau E
    Handb Exp Pharmacol; 2020; 261():87-104. PubMed ID: 32519163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fetal therapy of skeletal dysplasias].
    Murotsuki J
    Clin Calcium; 2013 Dec; 23(12):1784-8. PubMed ID: 24292533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the evaluation and treatment of osteogenesis imperfecta.
    Harrington J; Sochett E; Howard A
    Pediatr Clin North Am; 2014 Dec; 61(6):1243-57. PubMed ID: 25439022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type V osteogenesis imperfecta: a new form of brittle bone disease.
    Glorieux FH; Rauch F; Plotkin H; Ward L; Travers R; Roughley P; Lalic L; Glorieux DF; Fassier F; Bishop NJ
    J Bone Miner Res; 2000 Sep; 15(9):1650-8. PubMed ID: 10976985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone formation markers in adults with mild osteogenesis imperfecta.
    Cundy T; Horne A; Bolland M; Gamble G; Davidson J
    Clin Chem; 2007 Jun; 53(6):1109-14. PubMed ID: 17434905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypophosphatasia].
    Tsiantouli E; Trombetti A; Ferrari S
    Rev Med Suisse; 2017 Apr; 13(559):855-858. PubMed ID: 28727343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypophosphatasia : What is currently available for treatment?].
    Schmidt T; Amling M; Barvencik F
    Internist (Berl); 2016 Dec; 57(12):1145-1154. PubMed ID: 27796472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of pediatric bone and growth disorders: Of diagnostic workhorses and new horizons.
    Mehany SN; Patsch JM
    Wien Med Wochenschr; 2021 Apr; 171(5-6):102-110. PubMed ID: 33570693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypophosphatasia in Adults: Clinical Assessment and Treatment Considerations.
    Shapiro JR; Lewiecki EM
    J Bone Miner Res; 2017 Oct; 32(10):1977-1980. PubMed ID: 28731215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy approaches for osteogenesis imperfecta.
    Niyibizi C; Wang S; Mi Z; Robbins PD
    Gene Ther; 2004 Feb; 11(4):408-16. PubMed ID: 14724682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.